SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-015456
Filing Date
2024-01-25
Accepted
2024-01-25 16:33:51
Documents
14
Period of Report
2024-01-25
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d749889d8k.htm   iXBRL 8-K 23254
2 EX-99.1 d749889dex991.htm EX-99.1 8248
6 GRAPHIC g749889g0125070022265.jpg GRAPHIC 2975
  Complete submission text file 0001193125-24-015456.txt   160930

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA btmd-20240125.xsd EX-101.SCH 2832
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE btmd-20240125_lab.xml EX-101.LAB 17978
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE btmd-20240125_pre.xml EX-101.PRE 11246
8 EXTRACTED XBRL INSTANCE DOCUMENT d749889d8k_htm.xml XML 3348
Mailing Address 1875 W. WALNUT HILL LN #100 IRVING TX 75038
Business Address 1875 W. WALNUT HILL LN #100 IRVING TX 75038 972-486-9346
biote Corp. (Filer) CIK: 0001819253 (see all company filings)

IRS No.: 851791125 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40128 | Film No.: 24562672
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)